Literature DB >> 11952145

Activation and inhibition of virus and interferon: the herpesvirus story.

Karen L Mossman1.   

Abstract

Viral infection of a host leads to induction of an immune system attack against the virus along with a counterattack by the virus against the host. Interferons are highly upregulated upon viral infection and function as key regulators of the host innate defense system. Whereas many RNA viruses are sensitive to the effects of interferon, several of the large DNA viruses are relatively resistant, given their capacity to encode proteins that disarms the host response. The herpesvirus family is a large and diverse family of viruses that infects vertebrates and invertebrates and possesses the ability to remain latent in their host for life. This paper summarizes the relationship between herpesviruses and interferon, including the ability of herpesviruses to induce interferon production, mechanisms by which interferon decreases herpesvirus replication, and strategies of herpesviruses to counteract these mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11952145     DOI: 10.1089/088282402317340198

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  9 in total

1.  Diagnostic and therapeutic management of a severe acyclovir-resistant acute retinal necrosis in a young child.

Authors:  T H C Tran; F Rozenberg; A M Fillet; B Bodaghi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09-17       Impact factor: 3.117

2.  SARS-CoV regulates immune function-related gene expression in human monocytic cells.

Authors:  Wanchung Hu; Yu-Ting Yen; Sher Singh; Chuan-Liang Kao; Betty A Wu-Hsieh
Journal:  Viral Immunol       Date:  2012-08       Impact factor: 2.257

3.  Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency.

Authors:  Erik S Barton; Mary L Lutzke; Rosemary Rochford; Herbert W Virgin
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 4.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo.

Authors:  Jeremy O Jones; Ann M Arvin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Selective ablation of virion host shutoff protein RNase activity attenuates herpes simplex virus 2 in mice.

Authors:  Maria Korom; Kristine M Wylie; Lynda A Morrison
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

7.  Superinfection prevents recombination of the alphaherpesvirus bovine herpesvirus 1.

Authors:  François Meurens; Frédéric Schynts; Günther M Keil; Benoît Muylkens; Alain Vanderplasschen; Pierre Gallego; Etienne Thiry
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway.

Authors:  Shin-ichi Yokota; Noriko Yokosawa; Tamaki Okabayashi; Tatsuo Suzutani; Shunsuke Miura; Kowichi Jimbow; Nobuhiro Fujii
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Development of an attenuated vaccine against Koi Herpesvirus Disease (KHVD) suitable for oral administration and immersion.

Authors:  Sandro Klafack; Lars Schröder; Yeonhwa Jin; Matthias Lenk; Pei-Yu Lee; Walter Fuchs; Jean-Christophe Avarre; Sven M Bergmann
Journal:  NPJ Vaccines       Date:  2022-09-06       Impact factor: 9.399

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.